Article Text
A difficult case
Iatrogenic cerebral radiation necrosis
Abstract
Cerebral radiation necrosis is the most serious late reaction to high doses of ionising radiation to the brain, and its treatment is generally unsatisfactory. We present a patient who developed cerebral radiation necrosis after protracted fluoroscopy during repeated embolisations of an extracranial arteriovenous malformation. Treatment with bevacizumab (a humanised murine monoclonal antibody against vascular endothelial growth factor) was followed by neurological and radiological improvements.
- cerebrovascular
- MR
- neuropathology
- radiotherapy
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Successful treatment of quadriparesis from radiation myelopathy with bevacizumab in a patient with metastatic breast cancer
- Overview of the current concepts in the management of arteriovenous malformations of the brain
- Radiation-induced optic neuropathy: a review
- Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation
- Radiation and the nervous system
- Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome
- Endovascular superselective treatment of brain tumors: a new endovascular era? A quick review
- Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
- Treatment of tongue telangiectasia in a patient with hereditary haemorrhagic telangiectasia
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD